Parasitologists play a vital role in global health by studying parasites and the diseases they cause, contributing to the development of preventive and therapeutic strategies. Their work is critical in understanding complex host-pathogen interactions, especially in tropical and subtropical regions where parasitic infections are more prevalent. Through field research and laboratory studies, they investigate the life cycles, transmission methods, and resistance patterns of organisms such as protozoa, helminths, and ectoparasites. These insights are essential for creating effective public health interventions and guiding the use of antiparasitic medications and diagnostics. Furthermore, parasitologists collaborate across disciplines, integrating molecular biology, epidemiology, and immunology to tackle emerging parasitic threats.
In recent years, advancements in molecular techniques and bioinformatics have significantly enhanced the ability of parasitologists to detect and monitor parasitic diseases. Their contributions are central to efforts in eradicating conditions like malaria, leishmaniasis, and schistosomiasis. By analyzing genomic data, they can identify drug resistance markers and develop targeted therapies, contributing to more personalized approaches to treatment. Additionally, parasitologists often work closely with veterinarians and ecologists to study zoonotic parasites, ensuring a One Health perspective that recognizes the interconnectedness of human, animal, and environmental health. Their expertise continues to be indispensable in shaping global strategies for infectious disease control and prevention.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States